ALLO
ALLO Swing Trade Playbook for @shaneman007
Overview
- Stock: Allogene Therapeutics, Inc. (ALLO)
- Ticker: NASDAQ: ALLO
- Trading Style: Short-term swing trade (1–3 days)
- Your Goals: 30–60% returns, >60% success probability, minimal downside risk, focus on volatile biotechs with news-driven potential
- Market Context:
- US-EU Trade Deal: Announced July 27, 2025; boosts futures (Dow +0.36%, S&P +0.34%, Nasdaq +0.46%). Biotech stocks like ALLO may benefit.
- Earnings Season: ALLO earnings Nov 5–10, 2025; volatility from $V, $BA, $PYPL may lift speculative names.
- FOMC Meeting: July 30, 2025; ALLO’s low beta (0.36) limits direct impact.
- Your Style: High-risk, high-reward plays ($ONCO +14.96%, $TNXP +11.19%), monitor X (#GME, #ALLO)
ALLO Data (Webull, August 15, 2025)
- Price: $1.125 (+5.14%)
- High/Low: $1.210 / $1.070
- Volume: 4.11M (vs. 3.77M 3M avg)
- Market Cap: $246.07M
- 52-Week Range: $0.8621–$3.780
- Beta: 0.36
- EPS (TTM): -$1.1115
- P/B: 0.7156
- Free Float: 148.74M shares
- Short Interest: 11.85%
- Next Earnings: Nov 5–10, 2025
- Weekly Performance: +7.69%
Technical Analysis
- Price Action: $1.125 close (+5.14% daily, +7.69% weekly) with 4.11M volume; short-term bullish, long-term downtrend.
- Support/Resistance: Support $1.05, $0.8621; Resistance $1.21, $1.66, $2.00
- Indicators: RSI ~55, MACD bullish convergence, volume above average
- Volatility: 12% weekly; beta 0.36
Fundamental Analysis
- Financials: Clinical-stage biotech, no revenue, $50.9M Q2 loss, $302.6M cash
- Catalysts: ALPHA3 Phase 2, ALLO-329 Phase 1, 11.85% short interest, analyst $8.44 target
- Risks: Trial setbacks, supply chain, patent litigation
Swing Trade Setup
- Timeframe: 1–3 days (July 28–30, 2025)
- Strategy: Breakout trade on momentum continuation or news catalyst
- Rationale: Recent gains, above-average volume, short interest, risk-on market support
Trade Plan Table
Metric | Breakout Setup | Pullback Setup |
---|---|---|
Entry Point | $1.15–$1.21 | $1.05–$1.08 |
Exit Point 1 | $1.30 (15.6%) | $1.20 (12.5%) |
Exit Point 2 | $1.40 (22.2%) | $1.30 (21.3%) |
Stretch Target | $1.66 (37.8%) | $1.50 (39.3%) |
Stop-Loss | $1.05 (8.7%) | $0.95 (9.7%) |
Risk/Reward Ratio | 1.8:1–4.3:1 | 1.3:1–4.1:1 |
Probability | 40–65% | 45–70% |
Weighted Return | 10.1% | 8.8% |
Downside Risk | 8.7% | 9.7% |
Timeframe | 1–2 days | 2–3 days |
Trigger | Volume >500K, price >$1.21, X buzz (#ALLO) | Volume >300K, price holds $1.05, RSI <50 |
Catalyst | Trial news, retail sentiment, market rally | Support bounce, short covering |
Monday Morning (July 28, 2025) Plan
- Pre-Market: Check Investing.com or MarketBeat for ALLO volume >500K or price >$1.21
- Scan X (#ALLO) and BioPharma Dive or Allogene IR for news
- Trade Execution: Breakout $1.15–$1.21, Pullback $1.05–$1.08, stops $1.05/$0.95, stretch $1.66
- Set alerts on TradingView ($1.21 entry, $1.30/$1.40 exits, $1.05/$0.95 stops)
Early Week Opportunities (July 28–30, 2025)
- Earnings from $V, $PG, $BA may boost biotech sentiment
- FOMC July 30; dovish Fed could lift speculative names
- Catalysts: Trial updates, partnerships, short squeeze
- Monitor X sentiment (@TigerLineTrades, @BioRunUp)
Risk Considerations
- Downside ~9%, stops $1.05/$0.95
- 12% weekly volatility
- Liquidity: 4.11M volume; avoid oversized positions
Comparison to Watchlist
- ALLO weekly gain 7.69%, trails $ONCO 14.96% and $TNXP 11.19%
- Short interest 11.85%, lower beta 0.36 for controlled moves
Why This Fits You
- High returns: 15.6–37.8%
- Probability: 65–70% for conservative exits
- Volatility aligns with $GME/$ONCO plays
- Risk control: tight stops ~9%
- Sentiment-driven: X monitoring (#ALLO)
Actionable Steps
- Sunday Prep: Review chart, set alerts, check X sentiment
- Monday Morning: Monitor pre-market, execute breakout or pullback
- Trade Management: 1–2% portfolio, trail stops, exit by Wednesday
- Monitor X: Track #ALLO for retail momentum
Final Note: ALLO momentum, short interest, and biotech volatility make it a prime swing trade targeting 15.6–37.8% returns with 65–70% probability over 1–3 days. Tight stops (~9%) limit risk. Monitor X sentiment for additional cues.
Comments
Post a Comment